VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 536 filers reported holding VANECK VECTORS ETF TR in Q4 2019. The put-call ratio across all filers is 1.06 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $4,081,000 | +58.1% | 111,254 | -0.7% | 0.67% | +39.1% |
| Q1 2020 | $2,582,000 | -40.6% | 112,065 | -24.5% | 0.48% | -31.1% |
| Q4 2019 | $4,345,000 | +35.6% | 148,390 | +23.7% | 0.70% | +5.8% |
| Q3 2019 | $3,205,000 | +4.5% | 119,980 | -0.0% | 0.66% | -4.8% |
| Q2 2019 | $3,067,000 | -26.2% | 119,981 | -36.6% | 0.69% | -33.6% |
| Q1 2019 | $4,157,000 | +40.8% | 189,130 | +35.1% | 1.04% | +16.0% |
| Q4 2018 | $2,952,000 | -15.2% | 139,981 | -25.6% | 0.90% | -9.9% |
| Q3 2018 | $3,483,000 | -17.4% | 188,076 | -0.6% | 1.00% | -20.5% |
| Q2 2018 | $4,219,000 | +1.5% | 189,130 | 0.0% | 1.26% | +21.2% |
| Q1 2018 | $4,157,000 | -5.4% | 189,130 | 0.0% | 1.04% | -5.2% |
| Q4 2017 | $4,395,000 | +1.2% | 189,130 | 0.0% | 1.09% | -2.1% |
| Q3 2017 | $4,342,000 | – | 189,130 | – | 1.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |